HRID539095
反应详情
EQUATION
反应方程式
REACTANTS
反应物
PRODUCTS
生成物
PROCEDURE
实验过程
3-(3-(3-fluoro-4-(1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)-4-(2-(piperazin-1-yl)phenyl)oxazolidin-2-one (36 mg, 43%) was prepared by the procedure described in Example 1, Step 9, using a mixture of tert-butyl 4-(2-(3-(3-(3-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)-2-oxooxazolidin-4-yl)phenyl)piperazine-1-carboxylate and tert-butyl 4-(2-(3-(3-(3-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-5-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)-2-oxooxazolidin-4-yl)phenyl)piperazine-1-carboxylate. LCMS (APCI+) m/z 526.1 [M+H]+.